The Auckland-based regenerative medicine company has finished its Symphony randomised controlled trial, a multi-centre study focused on treating diabetic foot ulcers, one of the most persistent and costly complications of diabetes.
Aroa Biosurgery reports promising trial milestone for advanced wound treatment
March 30, 2026 Australian Biotech
Latest Video
New Stories
-
New partnership aims to create national blueprint for earlier Alzheimer’s diagnosis and care
July 31, 2026 - - Latest News -
Industry associations still resisting non-disclosure agreements for negotiation
July 31, 2026 - - Latest News -
AUScelerate programs channel major investment into heart and diabetes innovations
July 30, 2026 - - Latest News -
New AusBiotech membership aims to help Australia’s early-stage life sciences founders thrive
July 30, 2026 - - Latest News -
CSL begins clinical trials to test higher-yield plasma manufacturing
July 30, 2026 - - Latest News -
AI will likely grow the HTA 'industrial complex', but it can also democratise the institution
July 30, 2026 - - Latest News -
AbbVie records 13-year streak as 'A Great Place to Work'
July 29, 2026 - - Latest News

